Compounders Past vs Present

In this episode of Motley Fool Money, Emily Flippen, Sanmeet Deo, and Jason Hall discuss capital compounders, focusing on companies that reinvest for rapid growth, leading to increased earnings and market values. They analyze recent earnings reports from both established compounders like Axon and MercadoLibre, as well as newer ones such as Hims & Hers and Palantir, debating whether their valuations are justified by their growth potential and future opportunities. The conversation also touches on the impact of tariffs on various businesses, with the panel identifying companies like On Holdings, Coca-Cola, and Ferrari as having strong pricing power to mitigate these costs.